|
|
|
|
EmtrivaNetherlands Corporate News (persbericht), About Truvada Truvada combines Emtriva(R) (emtricitabine) and Viread(R) (tenofovir disoproxil fumarate) in one tablet taken once a day in combination with ... Companies Anticipate Filing New Drug Application in Second Quarter ... Jan 9, 2006 Nieuwsbank (persbericht), Truvada combines Emtriva® (emtricitabine) and Viread® (tenofovir disoproxil fumarate) in one tablet taken once a day in combination with other antiretroviral ... Bristol-Myers Squibb and Gilead Announce Data Supporting ... Jan 9, 2006 Finanzen.net, Truvada combines Emtriva(R) (emtricitabine) and Viread(R)(tenofovir disoproxil fumarate) in one tablet taken once a day incombination with other antiretroviral ... Gilead, Bristol Won't Quit on HIV Drug Jan 9, 2006 TheStreet.com The combination pill contains Sustiva from Bristol-Myers and Truvada from Gilead. Truvada is a once-a-day combination of Emtriva and Viread from Gilead. ... Gilead Says HIV Pill May Be Available in '06 Jan 10, 2006 Los Angeles Times, Researchers showed that a single pill combining Gilead's Viread and Emtriva medicines and Bristol-Myers' Sustiva was equivalent to taking the three drugs ... Companies announce success in forming single-pill anti-HIV regimen Jan 9, 2006 The Advocate, Truvada into a single formulation. Truvada is already a combination pill containing Emtriva and Viread. The companies plan to file ... 3 Companies, Emory to Get 2006 GBP Deal of Year Honors Dec 20, 2005 PharmaLive.com (press release), Emory University received $525 million from Gilead Sciences and Royalty Pharma for monetizing its royalty stream from sales of Emtriva. ... Georgia Biomedical Partnership announces deal of the year awards Dec 20, 2005 Atlanta Business Chronicle, Sciences Inc. and Royalty Pharma Inc., for discovering the drug Emtriva, which treats HIV-1, the virus which causes AIDS. Cardiomems ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |